C3.ai(US:AI) Prnewswireยท2025-09-10 02:06Core Viewpoint - A class action lawsuit has been filed against C3.ai, Inc. due to allegations of misleading investors regarding the impact of the CEO's health on the company's business prospects, leading to a significant drop in stock price following disappointing financial results [2][3]. Group 1: Allegations and Impact - The lawsuit claims that C3.ai failed to disclose how the CEO's health affected the company's ability to close deals and that management was ineffective in mitigating this impact [2]. - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing these issues to "the reorganization with new leadership" and the CEO's health problems [2]. - Following this announcement, C3.ai's stock price fell from $22.13 per share on August 8, 2025, to $16.47 per share on August 11, 2025, marking a decline of over 25% [2]. Group 2: Legal Proceedings - Shareholders wishing to serve as lead plaintiff in the class action must submit their papers to the court by October 21, 2025 [3]. - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [3]. Group 3: Company Background - Robbins LLP is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses and improve corporate governance since 2002 [4].